Kennedy, A. D., Wittmann, B. M., Evans, A. M., Miller, L. A., Toal, D. R., Lonergan, S., . . . Pappan, K. L. (2018). Metabolomics in the clinic: A review of the shared and unique features of untargeted metabolomics for clinical research and clinical testing. Journal of Mass Spectrometry, 53(11), 1143. https://doi.org/10.1002/jms.4292
Chicago Style (17th ed.) CitationKennedy, Adam D., Bryan M. Wittmann, Anne M. Evans, Luke A.D Miller, Douglas R. Toal, Shaun Lonergan, Sarah H. Elsea, and Kirk L. Pappan. "Metabolomics in the Clinic: A Review of the Shared and Unique Features of Untargeted Metabolomics for Clinical Research and Clinical Testing." Journal of Mass Spectrometry 53, no. 11 (2018): 1143. https://doi.org/10.1002/jms.4292.
MLA (9th ed.) CitationKennedy, Adam D., et al. "Metabolomics in the Clinic: A Review of the Shared and Unique Features of Untargeted Metabolomics for Clinical Research and Clinical Testing." Journal of Mass Spectrometry, vol. 53, no. 11, 2018, p. 1143, https://doi.org/10.1002/jms.4292.